• Study of mirikizumab and tirzepatide for adults with moderate to severe Crohn’s disease who are overweight or obese

    Recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Bulgaria Czechia Denmark France +9

  • Study of ivosidenib maintenance treatment in patients with IDH1-mutated cholangiocarcinoma after standard chemotherapy

    Recruiting

    4 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study of trospium chloride and xanomeline tartrate (KarXT) for treating manic episodes in adults with bipolar I disorder

    Recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Croatia Romania Slovakia Spain Sweden

  • Study of luxdegalutamide and abiraterone combination in adult men with metastatic hormone-sensitive prostate cancer

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia France Germany Italy The Netherlands Poland +1

  • Study of trospium chloride and xanomeline tartrate (KarXT) for treatment of manic episodes in adults with bipolar I disorder

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Hungary Poland

  • Study of sacituzumab tirumotecan, pembrolizumab and chemotherapy combination for early-stage triple-negative breast cancer or hormone receptor-low positive/HER2-negative breast cancer

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Czechia Finland France Germany Greece +8

  • Study of VENT-03 tablets in adults with active cutaneous lupus erythematosus with or without systemic lupus erythematosus

    Recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Czechia France Hungary Poland Spain

  • Long-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials

    Recruiting

    3 1 1
    Investigated drugs:
    Austria Belgium Bulgaria Czechia Denmark France +7

  • Study of subcutaneous nivolumab with ipilimumab and chemotherapy in previously untreated patients with metastatic or recurrent non-small cell lung cancer

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Greece Italy Poland Romania

  • Study of CART84 Treatment for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia

    Recruiting

    2 1 1
    Investigated diseases:
    Spain

powered by